My watch list
my.bionity.com  
Login  

19 Current news about the topic hepatitis b

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
New combination therapy offers chance of curing hepatitis B

08-Feb-2021

Around 260 million people, more than three percent of the world's population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as cirrhosis of the liver or liver cancer. A cure is not yet possible with existing drugs. Scientists ...

more

image description
New Vaccine Platform for a Vaccination against Hepatitis B

Oral or Transdermal Vaccination Possible

03-Mar-2020

Scientists of the Paul-Ehrlich-Institut have researched a vaccine platform, which confers a very good immune response (B cell and T cell response) and protection against hepatitis B in the mouse model. The vaccine platform is based on virus-like particles (VLPs) of the hepatitis B virus. The VLPs ...

more

image description
Findings could lead to treatment of hepatitis B

07-Jun-2018

Researchers at the University of Delaware, working with colleagues at Indiana University, have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide. The discovery reveals previously unknown ...

more

image description
Stone age hepatitis B virus decoded

Viral DNA shows the hepatitis B virus has been circulating in Europe for at least 7.000 years

14-May-2018

An international team of scientists led by researchers at Kiel University in the scope the CRC 1266 “Scales of Transformation” and the Max Planck Institute for the Science of Human History has successfully reconstructed genomes from Stone Age and Medieval European strains of the hepatitis B ...

more

Sensitive new assay detects hepatitis B infection in single liver cells and serum

13-Apr-2018

Chronic hepatitis B virus (HBV) can progress to cirrhosis and hepatocellular carcinoma (HCC). A study describes a new HBV assay that offers advantages over currently used methods because it has the capability to detect closed circular DNA (cccDNA) in serum, single cells, and preserved tissue ...

more

From heroin addiction to alcohol-related problems

02-Mar-2017

Methadone programs and long-term therapy using other opioids evidently work. People addicted to heroin consume less heroin, cocaine and even alcohol at the beginning of the treatment. As a long-term study conducted by the University Psychiatric Hospital and the University of Zurich reveals, ...

more

image description
Tricks of Ticking time bomb Hepatitis B Virus

21-Jun-2016

Hepatitis B virus (HBV) causes hepatitis B, an infectious disease that afflicts 230 million people worldwide, thereof 440 000 in Germany. Persistence of the virus in liver cells leads to progressive organ damage in the patient and contributes to a high risk of cirrhosis and liver cancer ...

more

Treatment for chronic hepatitis B linked to increased rates of colorectal and cervical cancer

18-Apr-2016

A new study presented today demonstrates a potential link between treatment of long-term oral nucleos(t)ide analogues and an increased risk of colorectal (p=0.029) and cervical (p=0.049) cancer in patients with chronic Hepatitis B virus (HBV). The study results were presented at The International ...

more

Johnson & Johnson announces completion of Novira Therapeutics, Inc. acquisition

09-Dec-2015

Johnson & Johnson announced the completion of the acquisition of Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing therapies for curative treatment of chronic hepatitis B virus (HBV) infection. The transaction was originally announced on November 4, ...

more

First malaria vaccine receives positive scientific opinion from EMA

Mosquirix to be used for vaccination of young children, together with established antimalarial interventions

28-Jul-2015

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion for Mosquirix (Plasmodium falciparum and hepatitis B vaccine), for use outside the European Union (EU). The malaria vaccine Mosquirix, also known as RTS,S/AS01, was ...

more

Page 1 From 2
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE